In the literature, CAF-derived CXCL12 has been described to coat cancer cells, whereas immunohistochemical approaches of most studies indicate tumor cells as the primary source of CXCL12 (Biasci et al. 2020). This evidence concerns the gene CXCL12 and neoplasm.